Fahmy Ahmad M, Hardten David R
University of Minnesota, Minneapolis, MN, USA.
Clin Ophthalmol. 2011;5:465-72. doi: 10.2147/OPTH.S12291. Epub 2011 Apr 14.
This paper reviews recent advances and investigation in the treatment of ocular surface pathology. There is significant investment in this area, paralleling the growing demand for more effective alternatives to current treatments. Clinicians are becoming more aware of surface pathology, yet the ability to treat the most common forms of ocular pathology are still limited to the few medications approved by the US Food and Drug Administration. Medicines and devices currently under investigation are very promising. It is absolutely critical to understand the emerging options and think of their role in the treatment paradigm.
本文综述了眼表疾病治疗方面的最新进展和研究情况。该领域投入巨大，这与对当前治疗方法更有效替代方案的需求不断增长相平行。临床医生对眼表疾病的认识日益提高，但治疗最常见眼表疾病形式的能力仍局限于美国食品药品监督管理局批准的少数几种药物。目前正在研究的药物和器械前景十分广阔。了解这些新出现的选择并思考它们在治疗模式中的作用至关重要。
